Is There Potential for Repurposing Statins as Novel Antimicrobials?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Statins are members of a class of pharmaceutical widely used to reduce high levels of serum cholesterol. In addition, statins have so-called “pleiotropic effects,” which include inflammation reduction, immunomodulation, and antimicrobial effects. An increasing number of studies are emerging which detail the attenuation of bacterial growth and in vitro and in vivo virulence by statin treatment. In this review, we describe the current information available concerning the effects of statins on bacterial infections and provide insight regarding the potential use of these compounds as antimicrobial therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · cited 1×
“In the latter studies, inhibition of bacterial invasion was proposed to be due to the ability of simvastatin and mevastatin to inhibit the activation of Rho GTPase proteins as a result of the inhibition of the production of the isoprenoid intermediates farnesyl-pyrophosphate and geranylgeranyl-pyrophosphate, which are…”
BackgroundStructural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644 · cited 3×
“typically possess larger side chains than type 1 statins (3).”
BackgroundInfluential
Cited by
Saputo, S., Faustoferri, R. C., & Quivey, R. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-17 · Cited by 29
Dominguez, J., Mendes, A. I., Pacheco, A. R., Peixoto, M. J., Pedrosa, J., & Fraga, A. G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1266261 · Cited by 4
“Statins are one of the most common drugs used to lower cholesterol production for the treatment of hypercholesterolemia, having a great impact on reducing the incidence of atherosclerosis and preventing cardiovascular events (Hennessy et al., 2016).”
BackgroundSpanakis, M., Alon-Ellenbogen, D., Ioannou, P., & Spernovasilis, N. (2023) · Pharmacy · doi:10.3390/pharmacy11040130 · Cited by 3
Multifunctionality of statins as antimicrobials
Plotkin, B. J., Borrelli, A., Erbst, M., Zheng, V., Konaklieva, M. I., Schileru, N., & Sigar, I. M. (2022) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2022.11.3.0114 · Cited by 1
Metadata
- Authors
- Hennessy, E., Adams, C., Reen, F. J., & O'Gara, F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2016-09
- Volume
- 60
- Issue
- 9
- Pages
- 5111-5121
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2464239670
- Cited by
- 133
- References
- 3
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is There Potential for Repurposing Statins as Novel Antimicrobials? https://app.cochat.ai/papers/10.1128/aac.00192-16
- The paper
- Hennessy, E., Adams, C., Reen, F. J., & O'Gara, F. (2016). Is There Potential for Repurposing Statins as Novel Antimicrobials? Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00192-16
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.